{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:26:04Z","timestamp":1770751564639,"version":"3.50.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Augsburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Trauma Emerg Surg"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Tranexamic acid is widely accepted for hip fractures but there is no agreement about dose or application method and the use is still off label for hip fractures. The aim of our study was to find the best application method of tranexamic acid in patients with femoral neck fractures comparing total blood loss, hemoglobin and transfusion rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective single centre cohort study (level I trauma centre) with 2008 patients treated operatively for a proximal femur fracture between January 2016 and January 2022 was performed. 1\u00a0g of tranexamic acid was applied in 314 cases (systemic, topic or combined application) if patients consented. Patient data, surgical procedure, complications, and mortality were assessed. Haemoglobin levels, blood loss and transfusion rates were compared amongst application methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For 884 femoral neck fractures treated with arthroplasty blood loss was significantly reduced by tranexamic acid which 314 had received in total (1151.0\u00a0ml vs 738.28\u00a0ml; p\u2009&lt;\u20090.001). 151 patients received 1\u00a0g of tranexamic acid systemically which reduced blood loss from 1151 to 943.25\u00a0ml. Combined application of 1\u00a0g i.v. and 1\u00a0g topically reduced blood loss even further to 869.79\u00a0ml and topical application achieved the lowest total blood loss at 391.59\u00a0ml (average reduction of 759.41\u00a0ml compared to without tranexamic acid), p\u2009&lt;\u20090.001. Transfusion rate and amount of RBC units transfused were the lowest for topical use and showed the highest hemoglobin levels postoperatively. Complication rates did not differ for adverse vascular events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Tranexamic acid effectively reduces blood loss and transfusion rates and shows higher hemoglobin levels postoperatively, without increasing the risk of thromboembolic events after proximal femoral fractures. Single topic application of 1\u00a0g for arthroplasty treatment of femoral neck fractures has better results for blood loss reduction than single i.v. or combined application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00068-024-02675-9","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T11:45:30Z","timestamp":1737459930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tranexamic acid: single topical application for femoral neck fractures treated with arthroplasty results in lowest blood loss"],"prefix":"10.1007","volume":"51","author":[{"given":"Kurnoth","family":"Anna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timon","family":"R\u00f6ttinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonhard","family":"Lisitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Koenemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"F\u00f6rch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"2675_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3238\/arztebl.m2021.0238","volume":"118","author":"M Rupp","year":"2021","unstructured":"Rupp M, Walter N, Pfeifer C, Lang S, Kerschbaum M, Krutsch W, Baumann F, Alt V. The incidence of fractures among the adult population of Germany\u2014an analysis from 2009 through 2019. Dtsch Arztebl Int. 2021;118:665\u20139. https:\/\/doi.org\/10.3238\/arztebl.m2021.0238.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"2675_CR2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/gerona\/glt105","volume":"69A","author":"GS Tajeu","year":"2014","unstructured":"Tajeu GS, Delzell E, Smith W, et al. Death, debility, and destitution following hip fracture. J Gerontol A Biol Sci Med Sci. 2014;69A(3):346\u201353.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"2675_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/pl00004148","volume":"7","author":"B Gullberg","year":"1997","unstructured":"Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7(5):407\u201313. https:\/\/doi.org\/10.1007\/pl00004148.","journal-title":"Osteoporos Int"},{"issue":"1","key":"2675_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11657-017-0373-9","volume":"12","author":"A Naranjo","year":"2017","unstructured":"Naranjo A, Fern\u00e1ndez-Conde S, Ojeda S, Torres-Hern\u00e1ndez L, Hern\u00e1ndez-Carballo C, Bernardos I, Rodr\u00edguez S, Laynez P. Preventing future fractures: effectiveness of an orthogeriatric fracture liaison service compared to an outpatient fracture liaison service and the standard management in patients with hip fracture. Arch Osteoporos. 2017;12(1):112. https:\/\/doi.org\/10.1007\/s11657-017-0373-9.","journal-title":"Arch Osteoporos"},{"key":"2675_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jor.2016.10.019","volume":"14","author":"B Budair","year":"2017","unstructured":"Budair B, Ahmed U, Hodson J, et al. Are we all guilty of under-estimating intra-operative blood loss during hip fracture surgery? J Orthop. 2017;14:81\u20134. https:\/\/doi.org\/10.1016\/j.jor.2016.10.019.","journal-title":"J Orthop"},{"key":"2675_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12891-020-03922-x","volume":"22","author":"H Cui","year":"2021","unstructured":"Cui H, Chen K, Lv S, et al. An analysis of perioperative hidden blood loss in femoral intertrochanteric fractures: bone density is an important influencing factor. BMC Musculoskelet Disord. 2021;22:6. https:\/\/doi.org\/10.1186\/s12891-020-03922-x.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"2675_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00068-022-02090-y","volume":"49","author":"A Fenwick","year":"2023","unstructured":"Fenwick A, Pfann M, Mayr J, Antonovska I, Wiedl A, Feldmann M, Nuber S, F\u00f6rch S, Mayr E. Anticoagulants and fracture morphology have a significant influence on total blood loss after proximal femur fractures. Eur J Trauma Emerg Surg. 2023;49(1):173\u20139. https:\/\/doi.org\/10.1007\/s00068-022-02090-y.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"2675_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12891-016-1333-z","volume":"17","author":"L Cai","year":"2016","unstructured":"Cai L, Wang T, Di L, Hu W, Wang J. Comparison of intramedullary and extramedullary fixation of stable intertrochanteric fractures in the elderly: a prospective randomised controlled trial exploring hidden perioperative blood loss. BMC Musculoskelet Disord. 2016;17:475. https:\/\/doi.org\/10.1186\/s12891-016-1333-z.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"2675_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.injury.2010.02.015","volume":"42","author":"GH Smith","year":"2011","unstructured":"Smith GH, Tsang J, Molyneux SG, White TO. The hidden blood loss after hip fracture. Injury. 2011;42(2):133\u20135. https:\/\/doi.org\/10.1016\/j.injury.2010.02.015.","journal-title":"Injury"},{"issue":"2","key":"2675_CR10","doi-asserted-by":"publisher","first-page":"p173","DOI":"10.1093\/ageing\/afm161","volume":"37","author":"NB Foss","year":"2008","unstructured":"Foss NB, Kristensen MT, Kehlet H. Anaemia impedes functional mobility after hip fracture surgery. Age Ageing. 2008;37(2):p173-178.","journal-title":"Age Ageing"},{"issue":"6","key":"2675_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005131-200407000-00007","volume":"18","author":"EA Halm","year":"2004","unstructured":"Halm EA, Wang JJ, Boockvar K, et al. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma. 2004;18(6):369\u201374.","journal-title":"J Orthop Trauma"},{"issue":"11","key":"2675_CR12","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.injury.2020.07.061","volume":"51","author":"I Ashkenazi","year":"2020","unstructured":"Ashkenazi I, Schermann H, Gold A, Lin R, Pardo I, Steinberg E, Sternheim A, Snir N. Tranexamic acid in hip hemiarthroplasty. Injury. 2020;51(11):2658\u201362. https:\/\/doi.org\/10.1016\/j.injury.2020.07.061.","journal-title":"Injury"},{"issue":"7","key":"2675_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1046\/j.1537-2995.1999.39070694.x","volume":"39","author":"JL Carson","year":"1999","unstructured":"Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA, Hudson JI, Provenzano G. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion. 1999;39(7):694\u2013700. https:\/\/doi.org\/10.1046\/j.1537-2995.1999.39070694.x.","journal-title":"Transfusion"},{"issue":"2","key":"2675_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/1120700019897878","volume":"31","author":"A Arshi","year":"2021","unstructured":"Arshi A, Lai WC, Iglesias BC, McPherson EJ, Zeegen EN, Stavrakis AI, Sassoon AA. Blood transfusion rates and predictors following geriatric hip fracture surgery. Hip Int. 2021;31(2):272\u20139. https:\/\/doi.org\/10.1177\/1120700019897878.","journal-title":"Hip Int"},{"issue":"1","key":"2675_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.arth.2016.08.026","volume":"32","author":"JL Kim","year":"2017","unstructured":"Kim JL, Park JH, Han SB, Cho IY, Jang KM. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis. J Arthroplasty. 2017;32(1):320\u20135. https:\/\/doi.org\/10.1016\/j.arth.2016.08.026.","journal-title":"J Arthroplasty"},{"key":"2675_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/jcp.33.Suppl_14.41","volume":"14","author":"IM Nilsson","year":"1980","unstructured":"Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (Roy Coll Path). 1980;14:41\u20137.","journal-title":"J Clin Pathol Suppl (Roy Coll Path)"},{"key":"2675_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","volume":"376","author":"H Shakur","year":"2010","unstructured":"CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid o death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet. 2010;376:23\u201332.","journal-title":"Lancet"},{"key":"2675_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13018-017-0625-9","volume":"12","author":"J Lei","year":"2017","unstructured":"Lei J, Zhang B, et al. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. J Orthop Surg Res. 2017;12:124. https:\/\/doi.org\/10.1186\/s13018-017-0625-9.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"2675_CR19","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1186\/s12891-023-06725-y","volume":"24","author":"J Zhang","year":"2023","unstructured":"Zhang J, Fan X, Zheng Y, Wu J, Yuan X. Intravenous application of tranexamic acid in intramedullary nailing for the treatment of geriatric intertrochanteric fractures: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2023;24(1):614. https:\/\/doi.org\/10.1186\/s12891-023-06725-y.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"2675_CR20","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1007\/s00402-024-05325-2","volume":"144","author":"Y Khatib","year":"2024","unstructured":"Khatib Y, Bal G, Liu R, Ashaia W, Sorial R. A randomised controlled trial assessing the effect of tranexamic acid on post-operative blood transfusions in patient with intra-capsular hip fractures treated with hemi- or total hip arthroplasty. Arch Orthop Trauma Surg. 2024;144(7):3095\u2013102. https:\/\/doi.org\/10.1007\/s00402-024-05325-2.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"12","key":"2675_CR21","first-page":"378","volume":"30","author":"J Geddes","year":"2020","unstructured":"Geddes J, McConaghie G. Does perioperative use of tranexamic acid in hip fracture patients increase the risk of venous thromboembolism and reduce the need for postoperative transfusions? J Perioper Pract. 2020;30(12):378\u201382.","journal-title":"J Perioper Pract"},{"key":"2675_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12891-019-2670-5","volume":"20","author":"J Xi","year":"2019","unstructured":"Xi J, Hu Q, et al. Efficacy and safety of tranexamic acid in geriatric hip fracture with hemiarthroplasty: a retrospective cohort study. BMC Musculoskelet Disord. 2019;20:304. https:\/\/doi.org\/10.1186\/s12891-019-2670-5.","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"2675_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-002150","volume":"4","author":"R Gill","year":"2019","unstructured":"Gill R, Ganatra B, Althabe F. WHO essential medicines for reproductive health. BMJ Glob Health. 2019;4(6): e002150. https:\/\/doi.org\/10.1136\/bmjgh-2019-002150.","journal-title":"BMJ Glob Health"},{"issue":"1","key":"2675_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00068-022-02042-6","volume":"49","author":"A Fenwick","year":"2023","unstructured":"Fenwick A, Antonovska I, Pfann M, Mayr J, Wiedl A, Nuber S, F\u00f6rch S, Mayr E. Does tranexamic acid reliably reduce blood loss in proximal femur fracture surgery? Eur J Trauma Emerg Surg. 2023;49(1):209\u201316. https:\/\/doi.org\/10.1007\/s00068-022-02042-6.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"2675_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12891-017-1429-0","volume":"18","author":"P Zhang","year":"2017","unstructured":"Zhang P, Liang Y, et al. Combined application versus topical and intravenous application of tranexamic acid following primary total hip arthroplasty: a meta-analysis. BMC Musculoskelet Disord. 2017;18:90. https:\/\/doi.org\/10.1186\/s12891-017-1429-0.","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"2675_CR26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.62636","volume":"16","author":"R Doka","year":"2024","unstructured":"Doka R, Neibaur S, Mohammad S, Small R, Dirkx M, Yaish A, Brannan GD. Evaluation of the early administration of tranexamic acid in geriatric hip fractures in the emergency department: a retrospective study. Cureus. 2024;16(6): e62636. https:\/\/doi.org\/10.7759\/cureus.62636.","journal-title":"Cureus"},{"key":"2675_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.thromres.2016.02.027","volume":"141","author":"C Wang","year":"2016","unstructured":"Wang C, Kang P, Ma J, Yue C, Xie J, Pei F. Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: a double-blind, randomized controlled trial of different doses. Thromb Res. 2016;141:119\u201323. https:\/\/doi.org\/10.1016\/j.thromres.2016.02.027.","journal-title":"Thromb Res"},{"issue":"5","key":"2675_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"key":"2675_CR29","unstructured":"ASA Physical Classification System. American Society of Anesthesiologists. http:\/\/www.asahq.org\/Home\/For-Members\/Clincal-Information\/ASA-Physical-Status-Classification-System\/"},{"issue":"8","key":"2675_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1185\/03007999609115227","volume":"13","author":"F Mercuriali","year":"1996","unstructured":"Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin. 1996;13(8):465\u201378. https:\/\/doi.org\/10.1185\/03007999609115227.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"2675_CR31","first-page":"224","volume":"51","author":"SB Nadler","year":"1962","unstructured":"Nadler SB, Hidalgo JH. Prediction of blood volume in normal human adults. Surgery. 1962;51(2):224\u201332.","journal-title":"Surgery"},{"issue":"5","key":"2675_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","volume":"72","author":"PL McCormack","year":"2012","unstructured":"McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012;72(5):585\u2013617. https:\/\/doi.org\/10.2165\/11209070-000000000-00000.","journal-title":"Drugs"},{"issue":"11","key":"2675_CR33","doi-asserted-by":"publisher","first-page":"1416998","DOI":"10.3389\/fmed.2024.1416998","volume":"7","author":"M Bouras","year":"2024","unstructured":"Bouras M, Bourdiol A, Rooze P, Hourmant Y, Caillard A, Roquilly A. Tranexamic acid: a narrative review of its current role in perioperative medicine and acute medical bleeding. Front Med (Lausanne). 2024;7(11):1416998. https:\/\/doi.org\/10.3389\/fmed.2024.1416998.","journal-title":"Front Med (Lausanne)"},{"key":"2675_CR34","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1055\/s-0040-1710549","volume":"34","author":"A Abdallah","year":"2021","unstructured":"Abdallah A, Sallam A, et al. Topical tranexamic acid in total knee arthroplasty: does it augment the effect of intravenous administration in patients with moederate- to high-risk of bleeding? A randomized clinical trial. J Knee Surg. 2021;34:1570\u20138.","journal-title":"J Knee Surg"},{"issue":"1","key":"2675_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/bja\/aep314","volume":"104","author":"PJ Zufferey","year":"2010","unstructured":"Zufferey PJ, Miquet M, et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth. 2010;104(1):23\u201330. https:\/\/doi.org\/10.1093\/bja\/aep314.","journal-title":"Br J Anaesth"},{"key":"2675_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024350","volume":"9","author":"Q Sun","year":"2009","unstructured":"Sun Q, Li J, Chen J, et al. Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a metaanalysis of randomized controlled trials. BMJ Open. 2009;9: e024350. https:\/\/doi.org\/10.1136\/bmjopen-2018-024350.","journal-title":"BMJ Open"},{"key":"2675_CR37","doi-asserted-by":"publisher","first-page":"215145932211478","DOI":"10.1177\/21514593221147817","volume":"14","author":"A Wilharm","year":"2023","unstructured":"Wilharm A, Wutschke I, Schenk P, Hofmann GO. Tranexamic acid in hip hemiarthroplasty surgery: a retrospective analysis of perioperative outcome. Geriatr Orthop Surg Rehabil. 2023;14:21514593221147816. https:\/\/doi.org\/10.1177\/21514593221147817.","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"2675_CR38","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.otsr.2019.06.008","volume":"105","author":"L King","year":"2019","unstructured":"King L, Randle R, et al. Comparison of oral vs. combined topical\/intravenous\/oral tranexamic acid in the prevention of blood loss in total knee arthroplasty: a randomised clinical trial. Orthop Traumatol Surg Res. 2019;105:1073\u20137.","journal-title":"Orthop Traumatol Surg Res"},{"issue":"6","key":"2675_CR39","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","volume":"57","author":"CJ Dunn","year":"1999","unstructured":"Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57(6):1005\u201332. https:\/\/doi.org\/10.2165\/00003495-199957060-00017.","journal-title":"Drugs"},{"issue":"2","key":"2675_CR40","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1749-6632.1968.tb20322.x","volume":"146","author":"L Andersson","year":"1968","unstructured":"Andersson L, Nilsoon IM, Colleen S, Granstrand B, Melander B. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Ann N Y Acad Sci. 1968;146(2):642\u201358. https:\/\/doi.org\/10.1111\/j.1749-6632.1968.tb20322.x.","journal-title":"Ann N Y Acad Sci"},{"key":"2675_CR41","unstructured":"(2005) Transamin\u00ae (tranexamic acid) injection 5%, 10%: Japanese prescribing information. Daiichi Pharmaceutical Co., Ltd, Tokyo"},{"issue":"1","key":"2675_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF00554669","volume":"20","author":"A Pilbrant","year":"1981","unstructured":"Pilbrant A, Schannong M, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol. 1981;20(1):65\u201372. https:\/\/doi.org\/10.1007\/BF00554669.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"2675_CR43","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1213\/ANE.0b013e3181c7eb27","volume":"110","author":"DL Reust","year":"2010","unstructured":"Reust DL, Reeves ST, Abernathy JH 3rd, Dixon JA, Gaillard WF 2nd, Mukherjee R, Koval CN, Stroud RE, Spinale FG. Temporally and regionally disparate differences in plasmin activity by tranexamic acid. Anesth Analg. 2010;110(3):694\u2013701. https:\/\/doi.org\/10.1213\/ANE.0b013e3181c7eb27.","journal-title":"Anesth Analg"},{"issue":"8","key":"2675_CR44","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOSGlobal-D-24-00157","volume":"8","author":"SR Blumenthal","year":"2024","unstructured":"Blumenthal SR, Fryhofer GW, Stein MK, Zhang SE, Looby S, Mehta S. Variable efficacy of tranexamic acid in geriatric hip fractures treated with arthroplasty versus cephalomedullary nails. J Am Acad Orthop Surg Glob Res Rev. 2024;8(8): e24.00157. https:\/\/doi.org\/10.5435\/JAAOSGlobal-D-24-00157.","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"2675_CR45","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1302\/0301-620X.98B6.36645","volume":"98-B","author":"PT Tengberg","year":"2016","unstructured":"Tengberg PT, Foss NB, et al. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip. Bone Jt J. 2016;98-B:747\u201353.","journal-title":"Bone Jt J."},{"issue":"303","key":"2675_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jss.2024.08.021","volume":"19","author":"AD Dure","year":"2024","unstructured":"Dure AD, Halpern AI, Antar RM, Rivera CM, Gaddam M, Kartiko S. Tranexamic acid is not associated with a change in infection risk in trauma patients. J Surg Res. 2024;19(303):111\u20136. https:\/\/doi.org\/10.1016\/j.jss.2024.08.021.","journal-title":"J Surg Res"},{"issue":"1","key":"2675_CR47","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1038\/s41598-022-08948-w","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Zhang Z, Li J, Huang B, Jiang Z, Pan Y, He T, Hu Y, Wang L. Tranexamic acid protects against implant-associated infection by reducing biofilm formation. Sci Rep. 2022;12(1):4840. https:\/\/doi.org\/10.1038\/s41598-022-08948-w.","journal-title":"Sci Rep"},{"issue":"1","key":"2675_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00402-011-1387-1","volume":"132","author":"K Kleinert","year":"2012","unstructured":"Kleinert K, Werner C, Mamisch-Saupe N, Kalberer F, Dora C. Closed suction drainage with or without re-transfusion of filtered shed blood does not offer advantages in primary non-cemented total hip replacement using a direct anterior approach. Arch Orthop Trauma Surg. 2012;132(1):131\u20136. https:\/\/doi.org\/10.1007\/s00402-011-1387-1.","journal-title":"Arch Orthop Trauma Surg"}],"container-title":["European Journal of Trauma and Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-024-02675-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00068-024-02675-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-024-02675-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:07:36Z","timestamp":1770721656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00068-024-02675-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2675"],"URL":"https:\/\/doi.org\/10.1007\/s00068-024-02675-9","relation":{},"ISSN":["1863-9933","1863-9941"],"issn-type":[{"value":"1863-9933","type":"print"},{"value":"1863-9941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest.All authors, their immediate families, and any research foundation with which they are affiliated with did not receive any financial payments or other benefits from any commercial entity related to the subject of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We declare that the study has been performed in accordance with the Declaration of Helsinki and has been approved by the ethical Committee of the University of Regensburg ID number: 20\u20132155-101. As retrospective study no consent for participation was required. All authors read and approved of the final manuscript. All authors believe this study represents honest work. There has been no prior publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"31"}}